EMED OTC
Electromedical Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -50.0%
3Y: -87.5%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±4950.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$588K
-56.4% ▼
5Y CAGR: -6.6%
Gross Profit
$381K
-63.5% ▼
5Y CAGR: -8.4%
Operating Income
-$1M
+48.4% ▲
Net Income
-$1M
+51.1% ▲
EPS (Diluted)
$-0.00
+71.4% ▲
EBITDA
-$1M
+41.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $738K | $907K | $1M | $1M | $588K |
| YoY Growth | -11.1% | +23.0% | +26.7% | +17.3% | -56.4% |
| Cost of Revenue | $194K | $199K | $261K | $303K | $207K |
| Gross Profit | $544K | $708K | $889K | $1M | $381K |
| Gross Margin | 73.7% | 78.0% | 77.3% | 77.5% | 64.8% |
| R&D Expenses | $32K | $215K | $92K | $231K | $0 |
| SG&A Expenses | $4M | $4M | $2M | $2M | $1M |
| Operating Expenses | $4M | $5M | $2M | $3M | $1M |
| Operating Income | -$3M | -$4M | -$2M | -$2M | -$1M |
| Operating Margin | -429.1% | -418.8% | -139.5% | -153.1% | -181.0% |
| Interest Expense | $770K | $3M | $791K | $893K | $231K |
| Income Before Tax | -$4M | -$8M | -$3M | -$3M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$8M | -$3M | -$3M | -$1M |
| Net Margin | -524.7% | -934.6% | -301.6% | -195.8% | -219.6% |
| EPS (Diluted) | $-0.20 | $-0.24 | $-0.03 | $-0.01 | $-0.00 |
| EBITDA | -$3M | -$5M | -$3M | -$2M | -$1M |
| Shares Outstanding | 22M | 51M | 134M | 377M | 649M |